Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Camurus AB's total inventories for the quarter that ended in Jun. 2026 was €13.7 Mil. Camurus AB's average total inventories from the quarter that ended in Mar. 2026 to the quarter that ended in Jun. 2026 was €12.3 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Camurus AB's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was €5.98.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Camurus AB's Days Inventory for the
three
months ended in Jun. 2026 was 278.05.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Camurus AB's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.33.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Camurus AB's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.19.
Camurus AB (STU:7CA) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Camurus AB's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Camurus AB's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Camurus AB Total Inventories Related Terms
Camurus AB Total Inventories Historical Data
* Premium members only.
The historical data trend for Camurus AB's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Camurus AB (STU:7CA) has a Total Inventories of €13.7 Mil as of Jun. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Camurus AB and its competitors.
Is Camurus AB's Total Inventories too high?
Camurus AB's current Total Inventories is €13.7 Mil. Overall, Camurus AB has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Camurus AB's Total Inventories compare to VRTX and REGN?
Camurus AB's Total Inventories of €13.7 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Camurus AB and its competitors. Camurus AB's current Total Inventories is €13.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camurus AB stock overvalued right now?
Based on GuruFocus' analysis, Camurus AB (STU:7CA) is currently considered Fairly Valued. The stock's GF Value™ is €59.75, compared to a current price of €56.55 — trading 5.4% below its estimated fair value. The current Total Inventories is €13.7 Mil. Camurus AB's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Camurus AB (STU:7CA), the current Total Inventories is €13.7 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Camurus AB (STU:7CA) Overvalued in 2026?
Based on GuruFocus' analysis, Camurus AB stock appears to be undervalued.
The current stock price of €56.55 is trading 5.4% below its estimated GF Value™ of €59.75.
GuruFocus considers Camurus AB to be Fairly Valued.
Key valuation signals for STU:7CA:
Total Inventories: €13.7 Mil
GF Value™: €59.75 vs. price of €56.55 (5.4% below fair value)
No single metric tells the full story. See the STU:7CA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Camurus AB is a science-led biopharmaceutical company focused on developing and commercializing long-acting medicines for the treatment of severe and chronic diseases. It has two approved products, including treatments for opioid dependence, and a development pipeline supported by its FluidCrystal technology. Its clinical pipeline includes product candidates for conditions such as pain, cancer, endocrine, and metabolic diseases, developed in-house and in collaboration with international pharmaceutical companies. Its pipeline programs include CAM2029 for acromegaly, gastroenteropancreatic neuroendocrine tumors, and polycystic liver disease; CAM2038 for chronic pain; CAM4072 for genetic obesity disorders; CAM2043 for Raynaud's phenomenon; CAM4071 for endocrine disorders, among others.
82GF Score
Get the complete analysis for STU:7CA
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:7CA has been successfully added to your 
